Conduit Pharma Appoints Simon Fry To Board Of Directors
19 Nov 2024 //
GLOBENEWSWIRE
Conduit Pharmaceuticals Expands Autoimmune Pipeline
04 Nov 2024 //
GLOBENEWSWIRE
Conduit Pharmaceuticals Announces Debt Restructuring and Notes
01 Nov 2024 //
GLOBENEWSWIRE
Conduit Pharmaceuticals To Present At H.C. Wainwright Conference
28 Aug 2024 //
GLOBENEWSWIRE
Conduit Pharma Selects Indications For Autoimmune Disorder Candidate
12 Aug 2024 //
GLOBENEWSWIRE
Conduit Pharma Licenses Multiple Assets From AstraZeneca
08 Aug 2024 //
GLOBENEWSWIRE
Conduit Pharma Patents Lead Asset For Autoimmune Diseases
16 Jul 2024 //
GLOBENEWSWIRE
Conduit Pharmaceuticals to Join Russell 3000® Index
13 Jun 2024 //
GLOBENEWSWIRE
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
19 Mar 2024 //
GLOBENEWSWIRE
Conduit to Participate in the 14th Annual Jefferies London Healthcare Conference
02 Nov 2023 //
GLOBENEWSWIRE
Conduit Partners with ClinConnect on Cocrystal Development Program for AZD1656
11 Oct 2023 //
GLOBENEWSWIRE